{
    "Trade/Device Name(s)": [
        "ImmunoCAP Allergen d201, House dust mite",
        "ImmunoCAP Specific IgE Assay"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "K092050",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "September 08, 2009",
    "Summary Letter Received Date": "October 15, 2009",
    "Submission Date": "June 29, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) Immunological Test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "IgE specific to Blomia tropicalis (house dust mite)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100E",
        "ImmunoCAP 250",
        "ImmunoCAP 1000"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Automated in vitro quantitative assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Allergen d201, a quantitative immunoassay for allergen-specific IgE to Blomia tropicalis (house dust mite) on ImmunoCAP platforms.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitative measurement of allergen-specific IgE in serum or plasma to aid diagnosis of IgE-mediated allergic disorders, used with ImmunoCAP instruments in clinical or physician office laboratories.",
    "fda_folder": "Immunology"
}